Skip to content

A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

Ethnographic Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06683482
Enrollment
41
Registered
2024-11-12
Start date
2025-02-21
Completion date
2025-07-28
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The main goal of this ethnographic study is to learn a holistic and enriched view of the behaviors, actions, and views of a group of people with advanced breast cancer (ABC) cancer living in Spain. The primary objective of this study is to collect data on the psychosocial needs of (ABC) patients to identify spaces and strategies to improve these needs.

Interventions

OTHERNo intervention

No study drug will be administered as a part of this study.

Sponsors

Gilead Sciences
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

Key Inclusion Criteria: 1. Informed consent to individual in the qualitative study and to allow the recording of the interview for analyses purposes (individual and/or caregiver). 2. Women or men (individual and/or caregiver) over 18 years of age. 3. Confirmed diagnosis of triple-negative breast cancer (TNBC), hormone receptor (HR)+/ human epidermal growth factor receptor 2 (HER2)-, HER2+ unresectable locally advanced breast cancer (ULABC) or metastatic breast cancer (mBC) (individual). 4. Individuals must have initiated at least the firstline treatment. 5. Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale 0-2 (individual). 6. Ability to conduct interviews from home (individual and/or caregiver) or remotely (ie, with technology available for an online interview). Key

Exclusion criteria

1. Individual unable to collaborate in the collection of necessary information (alteration in mental status, noncollaboration, limited language comprehension). 2. Individual unable or unwilling to provide informed consent. Note: Other protocol defined Inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Responses to the Open-ended questionnairesUp to 4 weeksThis qualitative ethnographic study will be carried out through the transcriptions of open-ended interviews. The variables of interest will consist of a set of sociodemographic data, as well as results from emotional and psychological.

Secondary

MeasureTime frame
Number of Participants with Responses to the Open-ended Questionnaires Related to Intimacy and SexualityUp to 4 weeks
Number of Participants With Responses to the Economic Impact of the DiseaseUp to 4 weeks
Number of Participants With Responses Open-ended Interviews to Assess Importance of Hereditary BC, Genetic Testing and Generic Counselling in ABC PatientsUp to 4 weeks
Number of Participants With Responses to the Open-ended interviews to assess the Level of Insight and Opportunities for Access to Clinical Studies to Promote Research and Access to Novel Therapeutic OptionsUp to 4 weeks
Number of Participants With Responses to the Open-ended Interviews to Assess Whether There is any Difference Between the Analyses of the Above Characteristics by BC SubtypeUp to 4 weeks

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026